VDB-372314 · CVE-2026-52866 · GCVE-0-2026-52866

Apollo Pharmacy Blood Glucose Monitoring System 0x0110_v1.1.0 authorization

CVSS Meta Temp Score CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.	Current Exploit Price (≈) Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.	CTI Interest Score Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
5.4	$0-$5k	3.20

Summaryinfo

A vulnerability described as problematic has been identified in Apollo Pharmacy Blood Glucose Monitoring System 0x0110_v1.1.0. This affects an unknown function. Such manipulation leads to authorization. This vulnerability is traded as CVE-2026-52866. Access to the local network is required for this attack to succeed. There is no exploit available.

Detailsinfo

A vulnerability, which was classified as problematic, has been found in Apollo Pharmacy Blood Glucose Monitoring System 0x0110_v1.1.0. Affected by this issue is an unknown code block. The manipulation with an unknown input leads to a authorization vulnerability. Using CWE to declare the problem leads to CWE-862. The product does not perform an authorization check when an actor attempts to access a resource or perform an action. Impacted is availability. CVE summarizes:

An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.

The weakness was shared by Rishitha Pucchakayala. The advisory is available at apollopharmacy.in. This vulnerability is handled as CVE-2026-52866 since 06/10/2026. The exploitation is known to be easy. Access to the local network is required for this attack. No form of authentication is required for exploitation. The technical details are unknown and an exploit is not available. The structure of the vulnerability defines a possible price range of USD $0-$5k at the moment (estimation calculated on 06/19/2026).

There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.

If you want to get best quality of vulnerability data, you may have to visit VulDB.

Productinfo

Vendor

Apollo Pharmacy

Name

Blood Glucose Monitoring System

Version

0x0110_v1.1.0

CPE 2.3info

🔒

CPE 2.2info

🔒

CVSSv4info

VulDB Vector: 🔒
VulDB Reliability: 🔍

CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒

CVSSv3info

VulDB Meta Base Score: 5.4
VulDB Meta Temp Score: 5.4

VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔒
VulDB Reliability: 🔍

CNA Base Score: 6.5
CNA Vector (icscert): 🔒

CVSSv2info

AV	AC	Au	C	I	A
💳	💳	💳	💳	💳	💳
💳	💳	💳	💳	💳	💳
💳	💳	💳	💳	💳	💳

Vector	Complexity	Authentication	Confidentiality	Integrity	Availability
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock

VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍

Exploitinginfo

Class: Authorization
CWE: CWE-862 / CWE-863 / CWE-285
CAPEC: 🔒
ATT&CK: 🔒

Physical: No
Local: No
Remote: Partially

Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒

0-Day	Unlock	Unlock	Unlock	Unlock
Today	Unlock	Unlock	Unlock	Unlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: no mitigation known
Status: 🔍

0-Day Time: 🔒

Timelineinfo

06/10/2026 CVE reserved
06/19/2026 +9 days Advisory disclosed
06/19/2026 +0 days VulDB entry created
06/19/2026 +0 days VulDB entry last update

Sourcesinfo

Advisory: apollopharmacy.in
Researcher: Rishitha Pucchakayala
Status: Not defined

CVE: CVE-2026-52866 (🔒)
GCVE (CVE): GCVE-0-2026-52866
GCVE (VulDB): GCVE-100-372314

Entryinfo

Created: 06/19/2026 07:57
Changes: 06/19/2026 07:57 (73)
Complete: 🔍
Cache ID: 216::103